Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Patent protection obtained for IDEC-C2B8

May 24, 1996

Genentech completes investment in IDEC ahead of schedule

May 17, 1996

U.S. NDA filed for bropirimine

May 17, 1996

Promising clinical data for GVAX reported at scientific meeting

May 17, 1996

Human Genome Sciences claims chemokine beta-9 polypeptides and their antagonists

May 17, 1996

Melacine NDA filing in sight

May 10, 1996

Jenner Technologies in-licenses MTP-PE from Ciba

May 10, 1996

Allovectin-7 clinical results announced at AACR

May 3, 1996

Somatix receives patent coverage for GVAX

May 3, 1996

Preclinical results for DC101 presented at AACR

April 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...